About
Technology
Issues
FAQ
Links
Official Page
AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.